Abstract
Background: The legal implications associated with illicit drug use during pregnancy are significant, as providers are required to notify child protective services when a drug-exposed infant is identified. Case report: The case presented involves possible specimen mishandling in two infants at risk for in utero drug exposure and describes alternative methodologies available to confirm specimen identity. Conclusions: It is critical that institutions establish and adhere to stringent procedures when screening newborns.
Original language | English (US) |
---|---|
Pages (from-to) | 104-106 |
Number of pages | 3 |
Journal | Clinica Chimica Acta |
Volume | 511 |
DOIs | |
State | Published - Dec 2020 |
All Science Journal Classification (ASJC) codes
- Biochemistry
- Clinical Biochemistry
- Biochemistry, medical
Keywords
- Cocaine
- Genotype
- In utero drug exposure
- Maternal substance abuse
- Mislabeled specimen
- Newborn
- Short tandem repeat
- Urine drug screen